Bicocca Open Archive

Logo unimib boa
CARUGNO, ANDREA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 9.428
NA - Nord America 4.174
EU - Europa 3.249
SA - Sud America 1.051
AF - Africa 210
OC - Oceania 41
Continente sconosciuto - Info sul continente non disponibili 4
Totale 18.157
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.974
VN - Vietnam 3.467
SG - Singapore 2.246
CN - Cina 1.310
HK - Hong Kong 1.034
IT - Italia 1.020
BR - Brasile 786
RU - Federazione Russa 627
IE - Irlanda 365
DE - Germania 274
KR - Corea 265
IN - India 225
FR - Francia 169
SE - Svezia 149
ID - Indonesia 143
GB - Regno Unito 141
NL - Olanda 140
BD - Bangladesh 128
AR - Argentina 98
CA - Canada 90
FI - Finlandia 77
IQ - Iraq 66
MX - Messico 64
PK - Pakistan 64
TR - Turchia 64
ZA - Sudafrica 58
ES - Italia 51
PH - Filippine 50
AT - Austria 49
JP - Giappone 47
MY - Malesia 41
SA - Arabia Saudita 41
UA - Ucraina 40
AU - Australia 34
CO - Colombia 34
MA - Marocco 33
TH - Thailandia 33
UZ - Uzbekistan 31
CL - Cile 29
EC - Ecuador 28
PL - Polonia 26
ET - Etiopia 22
IR - Iran 21
KE - Kenya 21
AE - Emirati Arabi Uniti 20
AF - Afghanistan, Repubblica islamica di 19
UY - Uruguay 19
VE - Venezuela 18
CH - Svizzera 17
JO - Giordania 17
TN - Tunisia 17
PY - Paraguay 16
NP - Nepal 14
PT - Portogallo 14
BO - Bolivia 13
AL - Albania 12
LT - Lituania 12
PA - Panama 12
RO - Romania 11
AZ - Azerbaigian 10
PE - Perù 10
EG - Egitto 9
IL - Israele 9
NG - Nigeria 9
BE - Belgio 8
CZ - Repubblica Ceca 8
DZ - Algeria 8
KZ - Kazakistan 8
OM - Oman 8
TW - Taiwan 8
CR - Costa Rica 7
DO - Repubblica Dominicana 6
JM - Giamaica 6
NZ - Nuova Zelanda 6
SY - Repubblica araba siriana 6
AO - Angola 5
BG - Bulgaria 5
CD - Congo 5
PS - Palestinian Territory 5
RS - Serbia 5
TT - Trinidad e Tobago 5
HR - Croazia 4
KG - Kirghizistan 4
LU - Lussemburgo 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
YE - Yemen 4
GR - Grecia 3
HN - Honduras 3
KW - Kuwait 3
LB - Libano 3
LK - Sri Lanka 3
AM - Armenia 2
BB - Barbados 2
DK - Danimarca 2
EE - Estonia 2
GH - Ghana 2
GN - Guinea 2
HU - Ungheria 2
KH - Cambogia 2
Totale 18.117
Salva come PNG Salva come JPEG
Città #
Singapore 1.302
Ho Chi Minh City 1.091
Hong Kong 1.020
Hanoi 958
San Jose 725
Hefei 522
Ashburn 396
Dublin 353
Seoul 260
New York 256
Santa Clara 249
Milan 194
Chicago 156
The Dalles 151
Los Angeles 149
Chandler 148
Da Nang 130
Frankfurt am Main 128
Lauterbourg 102
Beijing 95
Jakarta 88
Dallas 85
Haiphong 82
São Paulo 79
Council Bluffs 74
Quận Bình Thạnh 73
Biên Hòa 67
Moscow 67
Boardman 66
Buffalo 63
Rome 62
Thái Nguyên 62
Ninh Bình 55
Ha Long 54
Vũng Tàu 51
Nuremberg 47
Helsinki 45
Hải Dương 43
West Jordan 40
Bắc Ninh 39
Can Tho 39
Quận Một 38
Rio de Janeiro 34
Amsterdam 32
Bắc Giang 32
Baghdad 31
Bologna 30
Orem 30
Quận Phú Nhuận 29
Tokyo 29
Naples 27
Kent 26
Lappeenranta 26
Toronto 26
Shanghai 25
Tashkent 25
London 24
Munich 24
Vinh 24
Vĩnh Tường 24
Hòa Bình 23
Lang Son 23
Seattle 23
Vienna 23
Phủ Lý 22
Sydney 22
Warsaw 22
Atlanta 21
Bangkok 21
Chennai 20
Lấp Vò 20
Mexico City 20
Florence 19
Guangzhou 19
Montreal 19
Quận Bảy 19
Brescia 18
Dhaka 18
Genoa 18
Lahore 18
Manila 18
Turin 18
Jeddah 17
Johannesburg 17
Kuala Lumpur 17
Montevideo 17
Nairobi 17
Paris 17
Phoenix 17
Curitiba 16
Huizen 16
Belo Horizonte 15
Brooklyn 15
Carate Brianza 15
Houston 15
Istanbul 15
Mumbai 15
Quảng Ninh 15
Quận Bốn 15
Quận Hai 15
Totale 10.932
Salva come PNG Salva come JPEG
Nome #
Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 1.578
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 547
Esperienza del centro di Bergamo 424
Esposizione e discussione della casistica bergamasca 395
Burden Clinico della Psoriasi Burden Psicologico della Psoriasi 391
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 386
Global fertility in 204 countries and territories, 1950-2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021 377
Epidemiological, Phenotypic, Histological, and Genetic Traits in Multiple and Familial Melanomas: a study of 333 cases 350
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 314
51042 Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 309
Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 297
Profilo super responder in corso di trattamento con bimekizumab: studio retrospettivo multicentrico nella psoriasi moderato-grave 261
Sfide terapeutiche ed esperienze a confronto 240
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 231
Addictive behavior and diseases in patients with chronic skin diseases: preliminary findings of a cross-sectional study in Europe 230
Esposizione e discussione dell’esperienza del centro con focalizzazione sui temi controversi 220
Awareness of obesity among patients with psoriasis 220
Serum Lipids Alterations in Patients Under Systemic JAK Inhibitors Treatments in Dermatology: Clinical Aspects and Management 215
Ambulatori multidisciplinari 211
Effectiveness of ixekizumab for the treatment of moderate‐to‐severe plaque psoriasis with involvement of difficult‐to‐treat areas: A 52‐week multicenter retrospective study 207
Comparative effectiveness of tildrakizumab 200 mg versus tildrakizumab 100 mg in psoriatic patients with high disease burden or above 90 kg of body weight: a 16-week multicenter retrospective study - IL PSO (Italian landscape psoriasis) 194
The risk of candidiasis during treatment with bimekizumab for the management of plaque psoriasis: A 16-week multicentre real-world experience - IL PSO (Italian Landscape Psoriasis) 186
Anorectal melanoma: systematic review of the current literature of an aggressive type of melanoma 185
Treatment of Psoriasis Patients with Latent Tuberculosis Using IL-17 and IL-23 Inhibitors: A Retrospective, Multinational, Multicentre Study 183
Efficacy and Safety of bimekizumab in elderly patients: real-world multicenter retrospective study - IL PSO (Italian Landscape Psoriasis) 181
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 179
Bimekizumab for the Treatment of Plaque Psoriasis With Involvement of Genitalia: A 16-Week Multicenter Real-World Experience - IL PSO (Italian Landscape Psoriasis) 174
A 3-Year Multicentric Study on Switching from Ustekinumab to Guselkumab in Partial Responders with Psoriasis—IL PSO (Italian Landscape Psoriasis) 172
Italian guidelines in diagnosis and treatment of alopecia areata 172
Efficacy and tolerability of tirbanibulin 1% ointment in the treatment of cancerization field: a real-life Italian multicenter observational study of 250 patients 165
Age-Related Variations in Clinical, Histological, and Genetic Characteristics in Multiple and Familial Melanomas: A Study of 333 Patients 164
HIV and mpox: evaluation of clinical course and outcomes from an international dermatologic registry 162
Effectiveness and safety of bimekizumab for the treatment of plaque psoriasis: a real-life multicenter study—IL PSO (Italian landscape psoriasis) 159
Diagnostic Imaging of Agminated Blue Lesions and Blue Lesions with Satellitosis: Case Series with a Concise Review of the Current Literature 159
“Learning to fly”: quando la pratica supera la teoria. La casistica dei centri 156
Monkeypox: an Italian, multicenter study of 104 cases 154
Italian Guidelines in patch testing - Adapted from the European Society of Contact Dermatitis (ESCD) 147
Clinical-epidemiological aspects of the Monkeypox 2022 epidemic: a multicenter study by the Italian SIDeMaST Group of Sexually Transmitted, Infectious and Tropical Diseases 146
Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global Burden of Disease Study 2019 145
Monitoraggio epidemiologico di un corso di e-learning per medici di medicina generale all’interno del Melanoma Multimedia Education Programme 145
A dermatologic assessment of 101 mpox (monkeypox) cases from 13 countries during the 2022 outbreak: Skin lesion morphology, clinical course, and scarring 139
Arrhythmias and other cardiovascular diseases in young patients (<40 years) with moderate/severe atopic dermatitis: A multicentric study in northern Italy 139
Midline Anterior Neck Inclusion Cyst in a Pediatric Patient: A Case Report and Literature Review with a Dermatologic Perspective 139
Thin Amelanotic and Hypomelanotic Melanoma: Clinicopathological and Dermoscopic Features 139
Long-term proactive management of psoriasis with calcipotriol and betamethasone dipropionate foam: an Italian consensus through a combined nominal group technique and Delphi approach 138
Safety of anti-IL-23 risankizumab treatment in a patient with severe psoriasis and Charcot-Marie-Tooth disease 136
Adult-onset tufted angiomas associated with an arteriovenous malformation in a renal transplant recipient: Case report and review of the literature 135
Mycosis fungoides: Association of KIR ligands and HLA-DQB1∗05 with bad prognosis of the disease 134
Fast Clinical Response of Bimekizumab in Nail Psoriasis: A Retrospective Multicenter 36-Week Real-Life Study 134
Diagnosis and management of cutaneous and anogenital lichen sclerosus: Recommendations from the Italian Society of Dermatology (SIDemaSt) 133
Epidemiological, Phenotypical, Histological and Genetic Characteristics of Patients with Multiple Melanomas: Study of 108 patients at ASST Papa Giovanni XXIII, Bergamo 133
Acute generalized exanthematous pustulosis with erythema multiforme-like lesions induced by Hydroxychloroquine in a woman with coronavirus disease 2019 (COVID-19) 131
Successful use of tralokinumab for the treatment of atopic dermatitis on the genitals 129
Characteristic of chronic plaque psoriasis patients treated with biologics in Italy during the COVID-19 Pandemic: Risk analysis from the PSO-BIO-COVID observational study 129
COVID-19 and biologics for psoriasis: A high-epidemic area experience—Bergamo, Lombardy, Italy 129
Narrowband UVB phototherapy for pediatric generalized pityriasis lichenoides 128
Monkeypox nell’esperienza del gruppo MTS 128
Bone marrow metastases: a systematic review of a neglected involvement in malignant melanoma 126
Management of patients with atopic dermatitis undergoing systemic therapy during COVID-19 pandemic in Italy: Data from the DA-COVID-19 registry 125
Prevalence, severity and clinical features of psoriasis in fingernails and toenails in adult patients: Italian experience 124
Italian guidelines for therapy of atopic dermatitis—Adapted from consensus-based European guidelines for treatment of atopic eczema (atopic dermatitis) 123
Hepatitis C infection in Italian psoriatic patients: Prevalence and correlation with patient age and psoriasis severity 122
Trattamento della psoriasi in placche in soggetti con infezione da HIV con inibitori della IL-23: dati di efficacia e sicurezza nel medio-lungo termine 122
Factors associated with adverse COVID-19 outcomes in patients with psoriasis—insights from a global registry–based study 120
Use of anti Il-23 p19 inhibitors in cancer patients with severe psoriasis, a multicentric Italian experience 120
Agreement on classification of clinical photographs of pigmentary lesions: Exercise after a training course with young dermatologists 117
Management of biological therapies for chronic plaque psoriasis during COVID-19 emergency in Italy 116
The new Italian SIDAPA Baseline Series for patch testing (2023): an update according to the new regulatory pathway for contact allergens 116
Vasculitides with cutaneous expression in children: Clinico-pathological correlations 115
Usefulness of in vivo photodiagnosis for the identification of tumor margins in recurrent basal cell carcinoma of the face 115
RNAscope in situ hybridization and RT-PCR for detection of SARS-CoV-2 in chilblain-like lesions: A clinical, laboratory and histopathological study 115
Mpox in persons living with HIV: results from an international dermatologic registry 115
Coronavirus disease 2019 (COVID-19) rash in a psoriatic patient treated with Secukinumab: Is there a role for Interleukin 17? 114
Mpox first skin lesion location: a reflection of mode of transmission? 114
Patients with bullous skin disease in a high-epidemic COVID-19 area, Bergamo, Italy 114
Childhood Pemphigus Vulgaris during COVID-19 Outbreak Successfully Treated with Prednisone and Azathioprine: A Case Report and Literature Review 113
An unconventional case of scurvy 112
Characteristics of Patients Experiencing a Flare of Generalized Pustular Psoriasis: A Multicenter Observational Study 110
Eruptive xanthomas after extensive tattooing: A case report and literature review 110
La diagnosi clinica, il ruolo del dermatologo 109
Pompholyx of the hands after intravenous immunoglobulin therapy for clinically isolated syndrome: A paediatric case 109
Rapid remission of atypical cutaneous lobular breast cancer metastases after aromatase inhibitor therapy: a case report and literature review 108
Efficacia e sicurezza dei farmaci anti IL 23 nel trattamento della psoriasi in placche in soggetti con infezione da HIV 107
Histologic features of long-lasting chilblain-like lesions in a paediatric COVID-19 patient 106
Artrite psoriasica ed early PsA Il paziente giovane/naive - casi clinici Il paziente sovrappeso/obeso - casi clinici Il paziente con comorbidità 106
Factors associated with hospitalization due to COVID-19 in patients with psoriasis: insights from a global registry 106
Patogenesi: cosa è utile sapere? 106
Specific IgE to Staphylococcus aureus superantigens in patients affected by bullous pemphigoid 105
IgA anti-epidermal transglutaminase autoantibodies: A sensible and sensitive marker for diagnosis of dermatitis herpetiformis in adult patients 105
Genetic telecounseling: evaluation of efficacy and outcomes through the Genetic Counseling Outcome Scale (GCOS) questionnaire in a cohort of patients with a suspected melanoma susceptibility syndrome 104
Cutaneous blastic plasmacytoid dendritic cell neoplasm: Successful palliative treatment with oral prednisone in an elderly patient 104
La terapia topica 104
IgA anti-epidermal transglutaminase autoantibodies: A simple test to improve differential diagnosis between dermatitis herpetiformis and atopic dermatitis 103
Metronidazole-induced linear immunoglobulin A disease in a patient suffering from ulcerative colitis: a case report and focused review of the literature 101
No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area - Bergamo, Lombardy, Italy 100
Cutaneous lupus erythematosus patients in a high-epidemic COVID-19 area, Bergamo, Italy 100
Risankizumab: un nuovo modo di gestire la malattia psoriasica 99
Patients Withdrawing Dupilumab Monotherapy for COVID-19-Related Reasons Showed Similar Disease Course Compared With Patients Continuing Dupilumab Therapy 98
Longitudinal Deep Fissure and Distal Onycholysis of the Right Thumb 96
Risk of severe COVID-19 associated with immune-modifying drugs: Data from PsoProtect and Global Rheumatology Alliance registries. 93
Totale 17.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.198
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.198
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023880 0 176 73 29 83 131 150 72 74 16 54 22
2023/20241.655 44 52 51 38 120 414 235 75 134 130 176 186
2024/20256.230 250 471 413 274 351 212 405 152 359 576 432 2.335
2025/20269.907 2.179 1.447 666 965 825 419 1.529 396 680 771 30 0
Totale 18.672